deal could be $70 m pa

In a letter to shareholders dated 31 Jan 2013...the company enclosed a spreadsheet providing a breakdown of 31 possible future contracts.

At the top of the list....and what would appear to be the most advanced of all theses deals is an item showing the customer has an approved drug for target release in 2014.

Under the heading...Next Value Event...it is shown, Commercial Supply Contract.(which is different wording to other future contract prospects)

Best if keen investors go to this stock exchange release of the 31 Jan 2013, and check for themselves.

I think the info on this spreadsheet (as I have deailed, is significant).

....obviously a deal worth $70m pa or say $500m over 7 years would be a step for the company